We investigated the antiischemic properties of a new compound,
S-15176, in an experimental model of rat liver subjected to 120-min normothermic
ischemia followed by 30-min reperfusion. Rats were divided into groups, pretreated with different doses of
S-15176 (1.25, 2.5, 5 and 10 mg/kg/day by
intramuscular injection) or
solvent alone, and subjected to the
ischemia--reperfusion process. Another group served as the
sham-operated controls.
Ischemia--reperfusion induced huge alterations of hepatocyte functions, namely, a decrease in
ATP content and bile flow, and membrane leakage of
alanine aminotransferase (ALAT) and
aspartate aminotransferase (ASAT). These effects were associated with alterations in mitochondrial functions characterized by (1) a decrease in
ATP synthesis, (2) a decrease in
NAD(P)H levels and mitochondrial membrane potential, and (3) an increase in mitochondrial swelling reflecting the generation of permeability transition. Pretreatment of rats with
S-15176 alleviated these deleterious
ischemia--reperfusion effects at both the cellular and mitochondrial levels in a dose-dependent manner. The protection of mitochondrial functions was almost complete at a dosage of 10 mg/kg/day. In addition, in vitro,
S-15176 totally abolished the swelling of isolated mitochondria induced by a
calcium overload with an IC(50) value of 10 microM. These data demonstrate that
S-15176 protects mitochondria against the deleterious effects of
ischemia-reperfusion and suggest that this protective effect could be related to the inhibition of the mitochondrial permeability transition.